WallStreetZenWallStreetZen

NASDAQ: VNDA
Vanda Pharmaceuticals Inc Stock Ownership - Who owns Vanda Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vanda Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mihael Hristos PolymeropoulosPresident and CEO2025-03-065,000$5.02
$25.10kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-03-065,000$5.01
$25.05kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-03-055,000$5.01
$25.05kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-03-055,000$5.03
$25.15kBuy
Mihael Hristos PolymeropoulosPresident and CEO2025-03-0310,000$4.71
$47.05kBuy
Gunther BirznieksSVP Business Development2025-03-0126,941$4.76
$128.24kSell
Kevin Patrick MoranSVP CFO Treasurer2025-03-0126,941$4.76
$128.24kSell
Mihael Hristos PolymeropoulosPresident and CEO2025-03-0195,999$4.76
$456.96kSell
Joakim WijkstromSVP Chief Marketing Officer2025-03-0115,520$4.76
$73.88kSell
Timothy WilliamsSVP General Counsel2025-03-0126,941$4.76
$128.24kSell

1 of 2

VNDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VNDA insiders and whales buy or sell their stock.

VNDA Shareholders

What type of owners hold Vanda Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.61%9,104,204$45.34MInstitution
James E. Flynn14.87%8,669,076$43.17MInsider
Renaissance Technologies LLC6.61%3,853,799$19.19MInstitution
Vanguard Group Inc6.01%3,506,287$17.46MInstitution
Kevin C. Tang4.66%2,715,852$13.52MInsider
Rho Ventures IV LP4.32%2,518,177$12.54MInsider
Dimensional Fund Advisors LP4.27%2,488,519$12.39MInstitution
Tang Capital Management LLC4.04%2,353,307$11.72MInstitution
Mihael Hristos Polymeropoulos3.94%2,295,731$11.43MInsider
Robert J. More3.42%1,995,976$9.94MInsider

1 of 3

VNDA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VNDA51.63%48.37%Net SellingNet Selling
CRVS55.78%44.22%Net Buying
MBX35.69%64.31%Net BuyingNet Buying
PROK17.46%39.91%Net Buying
ANNX81.65%18.35%Net BuyingNet Selling
View Top Biotech Stocks

Vanda Pharmaceuticals Stock Ownership FAQ

Who owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals (NASDAQ: VNDA) is owned by 73.92% institutional shareholders, 69.27% Vanda Pharmaceuticals insiders, and 0.00% retail investors. James E. Flynn is the largest individual Vanda Pharmaceuticals shareholder, owning 8.67M shares representing 14.87% of the company. James E. Flynn's Vanda Pharmaceuticals shares are currently valued at $43.17M.

If you're new to stock investing, here's how to buy Vanda Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.